1. Home
  2. PCRX vs UVE Comparison

PCRX vs UVE Comparison

Compare PCRX & UVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$23.04

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo UNIVERSAL INSURANCE HOLDINGS INC

UVE

UNIVERSAL INSURANCE HOLDINGS INC

HOLD

Current Price

$39.78

Market Cap

957.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCRX
UVE
Founded
2006
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Property-Casualty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
957.6M
IPO Year
2010
1996

Fundamental Metrics

Financial Performance
Metric
PCRX
UVE
Price
$23.04
$39.78
Analyst Decision
Strong Buy
Buy
Analyst Count
4
1
Target Price
$30.25
$40.00
AVG Volume (30 Days)
497.5K
203.9K
Earning Date
04-30-2026
04-23-2026
Dividend Yield
N/A
1.97%
EPS Growth
107.44
214.43
EPS
0.07
1.88
Revenue
$541,533,000.00
$1,603,915,000.00
Revenue This Year
$6.78
N/A
Revenue Next Year
$8.54
$2.88
P/E Ratio
$318.71
$21.04
Revenue Growth
26.04
5.48
52 Week Low
$18.80
$21.96
52 Week High
$27.64
$41.96

Technical Indicators

Market Signals
Indicator
PCRX
UVE
Relative Strength Index (RSI) 45.79 59.92
Support Level $21.80 $32.51
Resistance Level $24.20 $41.58
Average True Range (ATR) 1.23 1.22
MACD -0.20 -0.19
Stochastic Oscillator 21.31 52.06

Price Performance

Historical Comparison
PCRX
UVE

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About UVE UNIVERSAL INSURANCE HOLDINGS INC

Universal Insurance Holdings Inc is an insurance holding company. Through its subsidiaries, the company mainly offers property and casualty insurance and value-added insurance services. It develops, markets, and underwrites insurance products for consumers predominantly in the personal residential homeowners lines of business and performs all other insurance-related services for its primary insurance entities, including risk management, claims management, and distribution. The group offers the following types of personal residential insurance: homeowners, renters/tenants, condo unit owners, and dwelling/fire, through an independent agent network and online distribution channels across multiple states in the United States of America.

Share on Social Networks: